Tae Hyun Kang

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsGlycoconjugatesHorticultural crop protection (incl. pests, diseases and weeds)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular, biological, and multi-scale communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2026
Fully human antagonistic antibodies targeting FPR2 through dual extracellular-loop engagement for gastric cancer therapy.

|Dec 31, 2025
Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer.

Jin Kim, Dong Wook Shin, Jiyoung Lee

|Apr 15, 2024
Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.

Jae-Deog Kim, Ah-Ra Lee, Dah-Hyun Moon

|Nov 24, 2022
A robust antibody discovery platform for difficult-to-express G protein-coupled receptors.

Nam Hyuk Kim, Sumin Kang, Ga Hyeon Park

|Sep 10, 2021
Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in Clinic.

Jin Kim, Ji Young Lee, Han Gil Kim

|Nov 27, 2019
Publisher Correction: An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence.

Chang-Han Lee, Tae Hyun Kang, Ophélie Godon

Pageof 2

Frequent Collaborators

2 joint publications

Chang-Han Lee

2 joint publications

Makiko Watanabe

2 joint publications

George Delidakis

2 joint publications

Caitlin M Gillis